improves with slower dose escalation Vomiting, diarrhea, or constipation Bloating, heartburn, or stomach discomfort Reduced appetite and early fullness Fatigue or headache Less common side effects Injection-site reactions Fatigue or changes in taste Temporary mild hair thinning (limited evidence) Serious but rare risks Pancreatitis seek care immediately if you experience severe abdominal pain Gallbladder disease or gallstones Kidney complications, particularly from dehydration Thyroid C-cell tumor risk in patients with medullary thyroid cancer history or MEN2 Low blood sugar when combined with insulin or sulfonylureas Contact your provider immediately if you experience severe or persistent abdominal pain, constant vomiting, signs of dehydration, yellowing of the skin or eyes, or symptoms of low blood sugar

Cardiovasc Res 36:276281 Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M et al (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2
Blend Composition PEPTIDE COMPONENTS CJC-1295 no DAC: 5mg (Modified GRF 1-29) Ipamorelin: 5mg (Pentapeptide) Total Peptide: 10mg Ratio: 1:1 Equal blend PHYSICAL PROPERTIES Form: White lyophilized powder Solubility: Readily dissolves in water Stability: Enhanced compared to native GHRH Storage: Keep refrigerated 3646 F (28 C) Related products GHK-Cu $50.00 $90.00Price range: $50.00 through $90.00 NAD+ $40.00 $125.00Price range: $40.00 through $125.00 TB-500 $60.00 $90.00Price range: $60.00 through $90.00
With the 50 mg vial reconstituted in 1 ml, the concentration is fixed, so your unit count maps directly to milligrams
Many patients who initially struggle with side effects tolerate the medication well after adjustments to their escalation schedule